|
|
Navidea Biopharmaceuticals, Inc.
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
CC long term view:there will be patent apps for M1/M2 reprogramming in other diseasequestion ...there's also been a lot of science
developed, Dr. Rosol, over the last little while that M1/M2 programming,
whether in reverse or inverse, also may be applicable in many other
diseases and inflammations....And do
you believe that you will be -- we'll be seeing patent applications on
that in the future? Dr. Rosol ...So
I might have gone astray from what you originally asked, but that
patent is very important. There will be others coming along the way that
are related. There are some already. You just don't know about it yet
because they're not published. And this is a very hot and exciting area
in not just cancer research but in other diseases. |
|
|
return to message board, top of board |
